Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| C4 Therapeutics, Inc. | 33,347 | reported | 30 Aug 2023 | tx 14+423,000−12,814 |
| IMMUNOGEN INC | 0 | reported | 12 Feb 2024 | tx 6+734,238 |
| Seaport Therapeutics, Inc. | 0 | reported | 04 May 2026 | tx 3+70,382−21,052 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 May 2026 | CONVERSION | Seaport Therapeutics, Inc. | 6,702 | — | |
| 30 Apr 2026 | GRANT_AWARD | Seaport Therapeutics, Inc. | 63,680 | 0.00 USD | deriv |
| 04 May 2026 | CONVERSION | Seaport Therapeutics, Inc. | 21,052 | 0.00 USD | deriv |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 295,975 | — | deriv |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 51,625 | — | deriv |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 19,519 | — | deriv |
| 01 Feb 2024 | GRANT_AWARD | IMMUNOGEN INC | 19,519 | 0.00 USD | deriv |
| 18 Sept 2023 | GRANT_AWARD | IMMUNOGEN INC | 295,975 | 0.00 USD | deriv |
| 18 Sept 2023 | GRANT_AWARD | IMMUNOGEN INC | 51,625 | 0.00 USD | deriv |
| 30 Aug 2023 | EXERCISE | C4 Therapeutics, Inc. | 2,250 | — | |
| 30 Aug 2023 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 661 | 2.93 USD | |
| 30 Aug 2023 | EXERCISE | C4 Therapeutics, Inc. | 2,250 | 0.00 USD | deriv |
| 13 Feb 2023 | GRANT_AWARD | C4 Therapeutics, Inc. | 26,000 | 0.00 USD | |
| 13 Feb 2023 | GRANT_AWARD | C4 Therapeutics, Inc. | 125,000 | 0.00 USD | deriv |
| 30 Jan 2023 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 1,301 | 7.78 USD | |
| 30 Jan 2023 | EXERCISE | C4 Therapeutics, Inc. | 3,750 | — | |
| 30 Jan 2023 | EXERCISE | C4 Therapeutics, Inc. | 3,750 | 0.00 USD | deriv |
| 25 May 2022 | EXERCISE | C4 Therapeutics, Inc. | 3,750 | — | |
| 25 May 2022 | EXERCISE | C4 Therapeutics, Inc. | 3,750 | 0.00 USD | deriv |
| 14 Feb 2022 | GRANT_AWARD | C4 Therapeutics, Inc. | 26,250 | 0.00 USD | deriv |
| 14 Feb 2022 | GRANT_AWARD | C4 Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 21 Jun 2021 | GRANT_AWARD | C4 Therapeutics, Inc. | 136,000 | 0.00 USD | deriv |